Answers are grounded in this paper and cite their sources.
A dichlororuthenium(IV) complex of 5,10,15,20-tetrakis[(1S,4R,5R,8S)-1,2,3,4,5,6,7,8-octahydro-1,2:5,8-dimethanoanthrance-9-yl]porphyrin, [Ru(IV)(D(4)-Por)Cl(2)] (1), was prepared by heating [Ru(II)(D(4)-Por)(CO)(MeOH)] (2) in refluxing CCl(4). Complex 1 is characterized by (1)H NMR (paramagnetically shifted pyrrolic protons at delta(H) = -52.3 ppm), FAB-mass spectroscopies, and magnetic susceptibility measurement (mu(eff) = 3.1 mu(B)). The ruthenium complex exhibits remarkable catalytic activity toward enantioselective alkene epoxidation using 2,6-dichloropyridine N-oxide (Cl(2)pyNO) as terminal oxidant. The Ru(IV)-catalyzed styrene epoxidation is achieved within 2 h (versus 48 h for the 2-catalyzed reaction), and optically active styrene oxide was obtained in 69% ee and 84% yield (875 turnovers). Likewise, substituted styrenes and some conjugated cis-disubstituted alkenes (e.g., cis-beta-methylstyrene, cis-1-phenyl-3-penten-1-yne, 1,2-dihydronaphthalene, and 2,2-dimethylchromenes) are converted effectively to their organic epoxides in 50-80% ee under the Ru(IV)-catalyzed conditions, and more than 850 turnovers of epoxides have been attained. When subjecting 1 to four repetitive uses by recharging the reaction mixture with Cl(2)pyNO and styrene, styrene oxide was obtained in a total of 2190 turnovers and 69% ee. UV-vis and ESI-mass spectral analysis of the final reaction mixture revealed that a ruthenium-carbonyl species could have been formed during the catalytic reaction, leading to the apparent catalyst deactivation. We prepared a heterogeneous chiral ruthenium porphyrin catalyst by immobilizing 1 into sol-gel matrix. The heterogeneous catalyst is highly active toward asymmetric styrene epoxidation producing styrene oxide in 69% ee with up to 10,800 turnovers being achieved. The loss of activity of the Ru/sol-gel catalyst is ascribed to catalyst leaching and/or deactivation. On the basis of Hammett correlation (rho(+) = -1.62, R = 0.99) and product analysis, a dioxoruthenium(VI) porphyrin intermediate is not favored.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: